article with gary stafford...a couple of points worth noting:- exploration budget to increase to $25m next year- if sp continues to rise as production approaches, consideration will be given to using scrip for acquisitions
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%